Cargando…
Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19?
BACKGROUND: The most dreaded pandemic grappling world now, the Coronavirus Disease 2019 (COVID-19), chiefly involves the respiratory system; nevertheless, it is a multisystem disorder. Its involvement of the hepatic system is considerable; however, still emerging are its clinical implications and th...
Autores principales: | Kodavoor Vadiraj, Padmaprakash, Thareja, Sandeep, Raman, Nishant, Karantha, Sowmya C., Jayaraman, Muthukrishnan, Vardhan, Vasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801964/ https://www.ncbi.nlm.nih.gov/pubmed/35125781 http://dx.doi.org/10.1016/j.jceh.2022.01.004 |
Ejemplares similares
-
Clinical characteristics and clinical predictors of mortality in hospitalised patients of COVID 19 : An Indian study
por: Padmaprakash, K.V., et al.
Publicado: (2021) -
Is Cutaneous Manifestation of COVID-19 an Overhyped Concept? An Experience from an Advanced COVID-19 Care Center in India
por: Singh, Gautam K., et al.
Publicado: (2022) -
Mesenteric Panniculitis with Raised Alanine Transaminase Levels: A Rare Case Report from Pakistan
por: Mahmood, Samar, et al.
Publicado: (2019) -
Vaccination status and COVID-19 related mortality: A hospital based cross sectional study
por: Muthukrishnan, J., et al.
Publicado: (2021) -
New-onset diabetes mellitus with COVID-19: Coincidence or cause
por: Muthukrishnan, J., et al.
Publicado: (2021)